CJC-1295 No DAC + Ipamorelin
Research compound · Lyophilized powder
$79.99
Combined GHRH analog (CJC-1295 without DAC) and ipamorelin, 10 mg vial, for laboratory research. Not for human or veterinary use.
ANALYSIS
AnalysisLot Report Pending
Check the current report status and match documentation to your vial’s lot. This document applies only to the lot identified in the report. Analytical purity does not establish sterility, safety, effectiveness, suitability for administration, or fitness for any purpose outside lawful laboratory research.
| Form | Lyophilized powder in a sealed research vial |
|---|---|
| Lyophilized storage | Keep sealed, desiccated, and protected from light. Typical research storage is −4°F (−20°C) (or −112°F (−80°C) for longer holds). Unopened vials may be held at 36°F–46°F (2°C–8°C) for short periods. Follow your laboratory SOP. |
| Laboratory preparation | Any further preparation belongs in your laboratory SOP. This page does not provide reconstitution, dosing, or administration instructions. Warm sealed vials to room temperature before opening. |
| Documentation | Match any analytical report to the lot printed on the vial. Product photos are not a substitute for a lot-specific report. |
| Intended use | Laboratory research only. Not for human or veterinary use, consumption, or diagnostic or therapeutic procedures. |
This combination contains two research peptides investigated for their interactions with growth hormone-related signaling pathways. CJC-1295 No DAC is associated with GHRH receptor activity, while ipamorelin is studied for growth hormone secretagogue receptor activity.
| Compound | CJC-1295 No DAC + Ipamorelin |
|---|---|
| Research category | Combination peptide formulation |
| Components | CJC-1295 without DAC (modified GHRH analog, also described as Mod GRF 1-29); Ipamorelin. Combined labeled mass as shown in Available Sizes. Individual component masses are not listed on the current catalog record. |
| Physical form | Lyophilized powder |
| Available sizes | 10 mg |
| Research focus | Growth hormone-related receptor signaling |
| Purity / testing documentation | Lot report pending. |
CJC-1295 No DAC + Ipamorelin